ABSTRACT The aim of this study was to compare 2 stepwise covariate model-building strategies, frequently used in the analysis of pharmacokineticpharmacodynamic (PK-PD) data using nonlinear mixedeffects models, with respect to included covariates and predictive performance. In addition, the effects of stepwise regression on the estimated covariate coefficients were assessed. Using simulated and real PK data, covariate models were built applying (1) stepwise generalized additive models (GAM) for identifying potential covariates, followed by backward elimination in the computer program NONMEM, and (2) stepwise forward inclusion and backward elimination in NONMEM. Different versions of these procedures were tried (eg, treating different study occasions as separate individuals in the GAM, or fixing a part of the parameters when the NONMEM procedure was used). The final covariate models were compared, including their ability to predict a separate data set or their performance in crossvalidation. The bias in the estimated coefficients (selection bias) was assessed. The model-building procedures performed similarly in the data sets explored. No major differences in the resulting covariate models were seen, and the predictive performances overlapped. Therefore, the choice of model-building procedure in these examples could be based on other aspects such as analystand computer-time efficiency. There was a tendency to selection bias in the estimates, although this was small relative to the overall variability in the estimates. The predictive performances of the stepwise models were also reasonably good. Thus, selection bias seems to be a minor problem in this typical PK covariate analysis.
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ously estimated by the use of nonlinear mixed-effects models. One of the important aims in population PK-PD modeling is the establishment of relationships between parameters and covariates (ie, patient specific variables) to explain parameter variability and facilitate dose adjustment decisions.
Stepwise model building is frequently employed in population PK(-PD) covariate model building with NONMEM (the most widely used program for population PK(-PD) modeling). 1 For example, 58 of 60 papers (1999) (2000) (2001) ) related to covariate model building in NONMEM included stepwise procedures (the reference list is available from the authors). No previous comparison between covariate model building procedures has been reported in the literature. In this article we assess the performances of 2 (objective) model-building strategies that make use of stepwise procedures. In addition, we explore how the results of a (typical) covariate analysis can be affected by selection bias, a general problem in stepwise regression. The search for important covariates is not always straightforward, especially if there are large numbers of covariate-parameter relations to consider. In addition to finding the "right" (ie, true or predictive) covariate, the right functional form of the relation must be identified. This may require considerable analyst-and/or computer run-time. Different approaches to aid model building and reduce the number of models to explore have been considered. Maitre et al 2 suggested plotting individual empirical Bayes (posthoc) estimates of the parameters versus each of the covariates to discover potentially important covariates. These need to be included in the mixed-effects model in some way, often involving stepwise testing. Mandema et al presented a stepwise procedure, using generalized additive models (GAM), 3 which is commonly used (for example, see references [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] ) and has been implemented in the program Xpose.
14 Built in a stepwise additive way, the GAM makes use of posthoc parameter estimates that are regressed on the individual covariate values. Possible covariate relations are identified, then incorporated and tested in the population model. Another stepwise routine has been suggested in which the covariate model is built within the population model in NONMEM. 15 In this automated procedure the model is first built up by including a new parameter-covariate relation term in each step and, when no more terms can be included (based on a prespecified criterion), all terms are retested in the model by exclusion.
AAPS PharmSci 2002; 4 (4) article 27 (http://www.aapspharmsci.org). stepwise regression. Some of these include selection bias (ie, overestimation of the effects of the selected covariates), [16] [17] [18] possibly overstated importance of retained variables, and invalid distributional assumptions. 19 There are also concerns regarding the number of candidate variables and variables being collinear, as these could affect the number of noise variables and accurate predictor variables in the final model. 20 One suggested way to avoid the problem of selection bias and get unbiased coefficients is to specify a best guess model based on prior knowledge. 21, 22 As there is no investigation described in the literature, we also wanted to address the magnitude of the selection bias problem in the area of nonlinear mixed-effects modeling.
MATERIALS AND METHODS
Covariate models were built using 2 model-building procedures: (1) GAM for identifying candidate covariate effects and NONMEM to test the importance of found covariate terms (GAM-NM) and (2) NONMEM both in a stepwise search for possible covariate effects and in a following backward deletion step(s) (NM-NM). The procedures were applied to both simulated and real data. Different versions of the procedures were also tried; for example, to consider run-time saving possibilities or to account for time-varying covariates. A GAM constrained to mimic stepwise multiple linear regression (ie, no nonlinear relationships were allowed) was also tried. The predictive performances of the found models were assessed using either a separate data set (in the case of simulated data) or cross-validation (in the case of real data). The GAM, implemented in Xpose 3.0, 14 and NONMEM (version VI beta) were used. Estimation in NONMEM was performed using the first-order conditional estimation (FOCE) method with the interaction option. In the following, descriptions of the model-building strategies are followed by the details of the simulated and real PK data, and the different versions of the procedures. The simulations made to assess the magnitude of the selection bias incurred by the use of stepwise model-building are then explained.
Model building procedures

GAM-NM
The individual empirical Bayes estimates of the parameters were first obtained from a fit of a model without covariate effects (basic model). The GAM 3 was used, separately for each fixed effects parameter, regressing the parameter on the covariates trying both linear and nonlinear (natural cubic spline with 1 internal breakpoint) models. Model discrimination was based on the Akaike information criteria (AIC); in each step the model that decreased the AIC the most was retained. The search ended when no model decreased the AIC further. The covariate relations identified in the final GAM models, for all parameters, were incorporated in the mixed-effects model (full model), and covariates were deleted from the model in a stepwise manner using NONMEM. In each step all covariates were left out of the model, one at a time. The least important covariate, according to the likelihood ratio test based on the objective function value (OFV, approximately -2 times the log likelihood of the data), was dropped from the model unless the difference in OFV (DOFV, likelihood ratio) was larger than 6.63 (corresponding to P < .01). The final model was established when no more covariates could be excluded from the model. Covariate effects were modeled, in the mixed-effects model, as being proportional to the typical value of the parameters: (1) q1 is the typical value of the parameter, and 2 is the fractional change in the typical parameter with the covariate (COV). Continuous covariates were centered on their median values (medianCOV); 1 then represents the typical value of the parameter in an individual with medianCOV, and 2 the fractional change in the typical parameter with each unit's change from the median covariate value. Nonlinear models for continuous covariates were parameterized in terms of 2 slopes, joined at the median covariate value:
(2)
NM-NM
With the NM-NM routine the covariate model is built altogether within NONMEM in a stepwise manner, starting from the basic model. In each step, all possible parameter-covariate combinations are tried, and inclusion of covariate effects is based on the likelihood ratio test. Continuous covariates are first tried in linear relations to the parameters. Once a covariate has been included in the model it is also tried, in the next step, in a nonlinear relation to the parameter. Covariate effects were parameterized as described above. The covariate relationship that gives rise to the largest OFV is retained in the model, given that inclusion results in OFV>3.84 (corresponding to P < .05). The full model is established when no more covariates can be included according to this criterion. The covariate relations are then left out of the full model 1 at a time and tested using a stricter criterion ( OFV>6.63), in the same way as for GAM-NM, described above.
Simulated data
Data sets
Ten simulated data sets were used in the comparison (previously used in Jonsson and Karlsson 15 ). These were generated from a 1-compartment model with firstorder absorption under steady-state conditions. The data sets contained on average 3 (range, 1-4) observations from each of 64 individuals, 230 observations in total. (Samples were drawn at 0.5, 2, 4, and 6 or 0.5, 2, 8, and 12 hours post-dose in half of the individuals.) The inter-
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, where i is a normally distributed random variable, with zero mean and variance 2 , accounting for the difference between the individual (P i ) and typical ( ) parameter estimate in the population. A proportional residual error was used in the simulations (Equation 4), where ij is a zero mean, normally distributed random variable with variance 2 .
(3)
In the simulation model, apparent clearance (CL/F, CL/F = 20 L/h, CL/F 25%) was related to gender ( SEX = 0.195) and nonlinearly to age (constant below median age, linearly decreasing above median age (years), AGE = -0.0385), and apparent volume of distribution (V/F, V/F = 100 L, V/F 25%) was related to concomitant medication with hydrochlorothiazide ( HCTZ = -0.560) and bodyweight (kg) ( WT = 0.006). The absorption rate constant ( Ka = 2 h -1 , Ka 20%) was not influenced by covariate effects. The residual error ( ) was 15%. The covariate data, summarized in Table 1 Table 1 , were taken from a clinical trial of the antihypertensive drug prazosin. 
GAM-NM simulated data
To explore possible differences in the resulting covariate models, the GAM-NM procedure was repeated for all simulated data sets using both the individual empirical Bayes estimates of the parameters (GAM(parameter)-NM) and the hi (GAM(eta)-NM). Covariate models were built for CL/F and V/F. A GAM, using posthoc parameter estimates, in which the model scope was limited to linear relationships (similar to multiple linear regressions) was also tried (Linear GAM-NM).
NM-NM simulated data
Covariate models for all data sets were established for CL/F and V/F. Fixing some parameter values during model building may shorten the run-times of the NM-NM procedure. To explore the effect of fixing parameter values, the NM-NM covariate models were built using the following variations: (1) estimating all parameters, (2) fixing structural parameter values (eg, CL/F and V/F) to the estimates from the fit of the basic model, and (3) fixing all structural and variance parameters (apart from the residual error and the explored covariate effects). Last, all parameters of the final models were estimated.
Assessment of predictive performance
The covariate models found in the inclusion step (full models) and after the backward step (final models), by the different procedures, were compared with respect to covariate terms. Two covariate models may be equally valuable (ie, have equal predictive capability) even though they differ with respect to included covariate terms-for instance, if covariates are correlated. To consider this aspect, the predictive performance of the found models was evaluated using a separate test data set. This test data set was generated by replication of the covariate data 200 times (ie, generating 12 800 subjects), and simulating new concentrations from the simulation model (with new hs and es). The parameters of each final model were fixed and used to predict the observations in the test data set. The root mean square error (RMSE) and the mean prediction error (MPE) were calculated for measuring predictive performance. This calculation was made using the log of the observed (simulated) concentrations and the log of the predictions for the typical individual to account for heteroscedasticity in the data. The MPE and RMSE of the models derived by the GAM-NM and NM-NM procedures were compared with the same quantities obtained from both the fits of the basic and simulation models and the part of the simulation models supported by the data. The latter was obtained by applying stepwise backward elimination in NONMEM, starting from the simulation covariate model.
The real data set
Data set
The real PK data set has been analyzed previously and is described in the literature. 3, 23, 24 The basic structural pharmacokinetic model was adopted from these earlier analyses, and only the influence of covariate effects was explored. The data originates from multiple IV infusions of a broad-spectrum antibiotic (pefloxacin) to 74 critically ill patients (200 or 400 mg over 1 hr). Approximately 3 samples were drawn from each individual at each of 1 to 3 occasions (visits) (time-course 2.5-14 days); in total 337 plasma concentrations were obtained. The basic model describing the data was a 1-compartment model parameterized in terms of clearance (CL) and volume of distribution (V), with interoccasion variability (IOV) in CL and V, and IIV in CL. Equation 5 shows the model for IIV and IOV. This equation differs from Equation 1 by the term kik that accounts for the random variation of a parameter within an individual i between occasions k, where p is the approximate coefficient of variation of kik. The residual error was modeled to be proportional to the predicted concentrations (Equation 4) (5) The covariate data are summarized in Table 2 .
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Assessment of performance-cross-validation The final models were compared with respect to the found covariate relations. To get a nearly unbiased measure of the ability of the models to predict the data, a cross-validation approach was used. This was accomplished by splitting the data set in 10 parts (random allocation of individuals). The parameters of the final model were estimated using 9/10 of the data and were used to predict the remaining 10th. Estimation and prediction were repeated so that predictions for all individuals were generated. Predictive performance was assessed by calculation of standardized mean prediction error (SMPE) as a measure of bias, 25 and root mean square (standardized) error (RMSSE) as a measure of precision. SMPE is the mean of the difference between the observed and predicted concentration divided by the estimate of the standard deviation of the predicted concentration (SDCp). (6) The standardization was done for the same reason that the MPE and RMSE were computed on the log-scale for the simulated data. Because there is more than 1 observation per individual, and the prediction errors within an individual are correlated, only 1 observation per individual was used when calculating SMPE and RMSSE. These observations were chosen to be parameterinformation-rich (sensitive to changes in the parameter, P) based on the partial derivatives with respect to P from the basic model. The point with the largest partial derivative with respect to P was chosen to assess the ability to predict P. Ninety-five percent confidence intervals (CI) were constructed for SMPE and RMSSE.
Estimation of selection bias in NM-NM
To assess the magnitude of selection bias (ie, overestimation of the regression coefficients due to stepwise selection), when stepwise covariate model building is used in a relatively typical population PK model, 100 new data sets were simulated from the final (NM-NM with IOV) model-referred to as the simulation model-for the real data set. The same model was fitted to each of the new data sets to get unbiased estimates of the covariate coefficients. The NM-NM model-building routine was also applied to each of the simulated data sets, starting from a (basic) model without covariate relations. This resulted in 2 sets of estimates of the covariate coefficients: simulation model estimates (estimated with simulation model) and stepwise model estimates (estimated with final NM-NM model for each of the 100 data sets). All estimates were normalized by division by their respective simulation coefficients. Box-and-whiskers plots of normalized coefficients were constructed to visualize potential differences.
GAM-NM real data
Potential covariate relations were identified by the GAM procedure for the posthoc individual estimates of CL and V from 3 different models: (1) a model describing only IIV in the structural parameters (ie, without IOV), (2) a model with IIV and IOV (the model described above), and (3) a model without IOV but in which the observations originating from different study occasions were treated as being from separate individuals-to account for covariates varying over time. For model (3), a GAM with the model scope constrained to only linear relationships was also tried. The relations found were incorporated into the model with IOV, using the original individual data structure for all models, and then deleted in a stepwise manner in NONMEM.
NM-NM real data
Stepwise model building was performed using 2 approaches. In the first the covariate model was built starting from the model including IIV and IOV, and in the second both the IIV and the IOV was set to zero (ie, all observations were treated as originating from a single individual [naïve/data pooling]).
The biases of the stepwise model coefficients-the MPE between true coefficients and stepwise model estimates (expressed as a percentage of the true coefficient)-were determined. The true coefficient refers to the estimate from the selected covariate model in a large test 27 (http://www.aapspharmsci.org) . data set (see below); ie, the true coefficient was recalculated for each set of selected covariates. 17 The bias of the stepwise model coefficients was compared with the precision of the simulation model estimates (ie, the precision resulting if the simulation model was treated as the best guess model). Precision was expressed as the RMSE between simulation coefficients and simulation model estimates (in all 100 data sets) divided by the simulation coefficients for this model.
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Predictive performance-simulated pefloxacin models
The ability of the above final NM-NM covariate models to predict the concentrations of a separate test data set was also assessed. This test data set was obtained by replication of the pefloxacin covariate data 200 times (ie, generating 14 800 subjects), and simulation of new concentrations from the simulation model (with new s and s). Predictive performance of the 100 models found was calculated as RMSE and MPE (as described previously for the simulated prazosin data sets). For comparison, predictive performance was also computed for the fits of the simulation model, the fits of the basic model, and the simulation coefficients. 
Results Simulated data
The results from fitting a GAM to the s or to the individual parameter estimates were similar ( Tables 3 and 4 ) . When the hs were used, fewer false covariates were identified in the full (GAM) model than when the parameter estimates were used. However, most of the false covariates were excluded from the model in the backward NONMEM step, and the final models were comparable. Note that for data set 8, no covariates were found in the final GAM(parameter) model for CL/F, even though both age and sex were supported in this data set. No difference in bias could be detected (data not shown), but the RMSE was somewhat smaller for the models developed based on the s ( Figure 1 ). When the covariate models were built stepwise within NONMEM, the results were similar to when the GAM(eta)-NM was used. The final models were identical, although the full NM-NM model included both some additional true and some additional false covariates. Both these procedures detected almost all of the covariates supported by the data. The predictive performances of the final NM-NM and GAM(eta)-NM models (both with respect to RMSE and MPE) were the same, and not very different from that of the supported models. When the structural parameters were fixed to estimates from the basic model during the NM-NM procedure, fewer true covariate relations were found. The ability to find true covariate relations diminished further if the variance parameters also were fixed during model building; however, this also resulted in fewer false covariates (  Table 4 ). The precision in predicting the large simulated data set was reduced when the parameters were fixed while the model was built compared with when parameters were estimated. 2002; 4 (4) article 27 (http://www.aapspharmsci.org) . There was a tendency of the constrained linear GAM to find more false covariate relationships. However, after the backward step most of these were eliminated, and the predictive performance was of the same magnitude as when the NM-NM procedure with fixed parameters was used ( Figure  1 ). The real data set
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The covariate models identified in the GAM for the PK data set, using models without IOV, with IOV, or with different occasions treated as separate individuals, were comparable ( Table 5 ). The full model with each occasion treated as a separate individual included the most covariates, and this model also had the lowest OFV. When the models with and without IOV were used, the same covariates were identified to influence CL, while the models for V differed some. The OFV for the model with IOV was lower than that for the model without IOV. After the backward deletion step in NONMEM, the covariate models for CL were similar. The models with and without IOV differed by only 1 parameter (CEN) from the model in which each occasion was treated as a separate individual. The covariate models for V also differed by only 1 parameter. Parameter estimates from the covariate models are shown in Table 6 . When the GAM was constrained to use only linear relationships, the final model was exactly the same as when the GAM was unconstrained; the results are therefore only shown for the latter.
The full NM-NM model with IOV had a lower OFV than the full GAM-model in which each occasion was treated as a separate individual. However, the final models for these 2 model-building strategies were exactly the same. When the covariate model was built with NM-NM and the pooled data approach, the largest number of covariates were found, in both the full and final models.
In the cross-validation, the models showed similar predictive ability with respect to both SMPE and RMSSE (  Table 7 ). There was a small negative bias in the points influencing CL, while a small positive bias and a tendency to better predictions of the points influenced by V could be observed. Worth noting is that the model from the pooled data approach also predicts well. 
Estimation of selection bias in NM-NM
The stepwise NM-NM procedure selected the relationships CL-BIL and V-WT in 99 of the 100 simulated data sets, CL-CLCR in 96, V-CLCR in 80, CL-CEN in 75, CL-SEX and CL-AGE in 66, V-AP in 63, and V-BIL in 60. The true (ie, simulation) model was found in 7 data sets. Altogether, 54 false covariates were found in 40 of the data sets (24 on CL and 30 on V). Box-and-whiskers plots of the simulation model and stepwise (normalized) estimates for each covariate effect for CL are shown in Figure 2 . The simulation model estimates are shown for both all data sets and for the subset of data sets in which the covariate effect was selected by the stepwise procedure. For the covariate effects that were found in 99 of the 100 data sets (CL-BIL and V-WT [data not shown]), only minor differences could be detected between the simulation model and stepwise estimates. However, in the cases where the effects were found less frequently (eg, CL-SEX and CL-AGE) upward biases in the stepwise estimates were evident when compared with the simulation model estimates [from all data sets]. The simulation model estimates from the subset of data sets also showed a tendency of being upwards biased, which indicates that there is a selection bias. It could also be seen that the RMSE of the simulation model estimates always exceeded the MPE of the stepwise estimates (  Table 8 ), indicating that the bias is of less importance. 
Predictive performance-simulated pefloxacin
The ability of the stepwise model estimates to predict the concentrations of the simulated pefloxacin test data set was considerably better than that of the basic model without covariates, and slightly worse than that of the simulation model estimates regarding precision ( Figure  3 ). The overall biases (MPE) of the predicted concentrations were comparable between the stepwise and basic models (data not shown).
DISCUSSION
The main aim of the study was to explore and compare the properties of the GAM-NM and the NM-NM with respect to inclusion of true and false covariates and predictive performance. As the model-building procedures performed similarly in the data sets explored, we will not make a systematic comparison but focus on some main conclusions. The secondary aim was to address how a "typical" population PK analysis is affected by the known problems associated with stepwise regression, as the implications of its use in the field of PK-PD modeling have not been investigated previously. A tendency toward selection bias was seen, but it was relatively small compared with the variability in the estimates between data sets. While some minor differences could be seen between the GAM-NM and NM-NM covariate models, the variability between data sets was as large as the Figure 3 . Box-and-whiskers plots of root mean square error (RMSE) between the log of the observed (simulated) concentrations and the log of the predicted concentrations obtained with the basic, stepwise NM-NM, and simulation models, and the simulation coefficients for the 100 simulated pefloxacin data sets. The filled dot represents the median, the box range is the interquartile range, and the whiskers extend to values less than/greater than/equal to 1.5 times the interquartile range. Values beyond these limits are shown as empty dots.
AAPS PharmSci 2002; 4 (4) article 27 (http://www.aapspharmsci.org). variability between procedures, and the predictive performances overlapped. Also, minor differences within procedures were noted; but the final covariate models were essentially the same, regardless of whether the hs or parameters were used in the GAM. When there were true nonlinear relationships in the data, and the GAM was constrained to use only linear relationships (similar to stepwise linear regression), these relationships could obviously not be found; in addition, other true relationships were overlooked, which lead to a lower predictive ability. For the NM-NM search, there was a tendency toward a lower inclusion frequency of both true and false covariates when parameters were fixed. In these data sets, with sampling frequent enough to yield reasonably good individual parameter estimates, it is of little consequence, with respect to performance, which method is chosen. Hence, the choice must be based on other aspects of the procedures. The GAM is fast and, as it reduces the number of covariate relations to incorporate in the mixed-effects model, it is run-time efficient compared with the NM-NM procedure. Computer run-times can be a problem for NM-NM, especially since the procedure relies on significance levels derived from the likelihood ratio test. For many models (nonlinear models with heteroscedastic errors), the computerintensive FOCE method with -interaction must be used for these levels to equal the theoretical levels. 26 The relations found in the GAM must be included and tested in the NONMEM model; accordingly, the GAM-NM is not as analyst-time efficient as the NM-NM, which is fully automated. In many practical situations it is the data analyst time that is rate-limiting. The GAM does not account for covariates/parameters varying over time unless different occasions (visits) are treated as separate individuals. In circumstances in which this is not possible, the NM-NM would be preferred. Both procedures are prone to be affected by selection bias; however, the 2 methods were equal with respect to performance (and the GAM is often combined with a stepwise inclusion of the identified covariates in the mixed-effects model), thus the issue was only addressed with NM-NM. Stepwise model building did result in upward-biased estimates of the covariate coefficients, but the bias seemed minor compared with the imprecision of the estimates yielded when the true (simulation) model was applied. The overestimated effects may lead to poorer predictive performance of the model. However, the difference in predictive performance between the true (simulation) and stepwise models, in our example, was small. The frequency of false inclusion in the simulated pefloxacin and prazosin data sets indicated that when more variables were tested more false covariates were found in the final models, probably an effect of multiple testing. However, the term "false" may not be appropriate as one covariate could be substituting for another due to correlations and, therefore, might not be false at random. These results are limited to 1 data set, and the properties may be different in other (especially smaller) data sets. However, data sets for which exploratory covariate analysis is performed are usually larger (with respect to number of individuals) than our example (n = 74). The definition of a good model varies depending on its purpose. Frequently the model is used for making predictions, and good predictive ability is required. Simplicity is also desired; covariates not improving the predictive ability should not be included. The stepwise search is based purely on statistical criteria, but it may be advantageous to use other approaches, such as including predictive ability as a model-building criterion, or considering clinical significance in the process. Because clinical significance criteria vary from drug to drug incorporating them is not straightforward; however, using Bayesian modeling clinical significance has been included. 27 Another approach to covariate modeling was recently taken by Kowalski and Hutmacher, 28 who suggested evaluating all possible relations from the estimated variance-covariance matrix of the full (including all covariates) model fit. However, the practical usefulness of this procedure is still unclear, and we did not evaluate it. If the model is built for exploratory purposes, selection bias may be of minor importance; however, bias may represent a larger problem if the model is intended for prognostic purposes. To get unbiased estimates and predictions, one would preferably develop the model on one part of the data, estimate coefficients on a second part, and predict a third part. However, data are usually too precious to waste to be used in this fashion. Another option could be to prospectively consider known or expected characteristics of the drug in a best guess model and estimate these effects 21, 22 to get unbiased coefficients. An exploratory search can then be carried out starting from this model. 17 Considering only plausible covariates in the search limits the covariate scope and reduces the risk of erroneous effects (due to multiple testing). In addition, the problems with accuracy and precision that can occur if 2 highly correlated covariates enter a model simultaneously 29 can be avoided by excluding 1 of 2 highly correlated covariates. In summary, the properties of 2 stepwise covariate model-building procedures have been compared. No difference in performance could be seen in the data sets explored; however, there are differences with respect to practical advantages and disadvantages of the procedures. Upward biases in the stepwise estimated coefficients were evident, but these were small compared with the imprecision in the estimates under the true model.
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